Biocon shares drop 6% after USFDA inspection of Malaysian unit
The OAI status may cause delay or withholding of pending product approvals or supplements from the facility, Biocon says
syngene
October 2023
July 2021
November 2020
Mix and match vaccines, says Kiran Mazumdar-Shaw
In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.
Syngene’s winning formula
Syngene International was started by Biocon in 1993 to provide research services for pharma companies. Three decades later, the entity wants to become a global science company in its own right.
The consistent outliers of D-Street
Fortune India’s second edition of the Top 100 Wealth Creators sees 32 companies staying put from the 2019 list, despite the once-in-a-century survival challenges posed by the Covid-19 pandemic.
Stars of the bourses
Fortune India’s Top 100 Wealth Creators list is focussed on consistency as the key metric while picking the real stars of the bourses.
Healthcare leaders shine in MPW 2020 list
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
